Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease
- First Posted Date
- 2017-10-23
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 170
- Registration Number
- NCT03318276
- Locations
- 🇰🇷
Yonsei University College of Medicine, Severance Cardiovascular Hospital, Seoul, Korea, Republic of
Safety Study of NBP608 in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2017-04-20
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT03121638
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Immunogenicity and Safety of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over
- First Posted Date
- 2017-04-19
- Last Posted Date
- 2017-04-19
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 824
- Registration Number
- NCT03120364
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Guro-gu, Korea, Republic of
Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over
- First Posted Date
- 2017-04-17
- Last Posted Date
- 2017-04-17
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 675
- Registration Number
- NCT03116594
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Guro-gu, Korea, Republic of
The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2017-04-14
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 152
- Registration Number
- NCT03114982
- Locations
- 🇵🇭
Research Insitute for Torpical Medicine, Muntinlupa City, Metro Manila, Philippines
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months
- First Posted Date
- 2017-01-13
- Last Posted Date
- 2017-11-01
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 171
- Registration Number
- NCT03020628
- Locations
- 🇰🇷
Inje University Ilsan Paik Hospital, Goyang, Korea, Republic of
🇰🇷The Catholic University of Korea, Incheon ST. Mary's Hospital, Incheon, Korea, Republic of
🇰🇷Gachon University Gil Medical center, Incheon, Korea, Republic of
Immunogenicity and Safety Study of NBP606 in Healthy Toddlers
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-10-07
- Last Posted Date
- 2020-04-20
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 462
- Registration Number
- NCT02927444
- Locations
- 🇰🇷
Clinical Research Center, Seoul, Korea, Republic of
Safety/Tolerability and Pharmacokinetic Study of SID142
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 41
- Registration Number
- NCT02625714
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-12-03
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 454
- Registration Number
- NCT02621164
Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and Adolescents
- First Posted Date
- 2015-12-03
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- SK Chemicals Co., Ltd.
- Target Recruit Count
- 385
- Registration Number
- NCT02621177
© Copyright 2024. All Rights Reserved by MedPath